Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study
EndocrinologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- The Journal of clinical endocrinology and metabolism
- Publicado em
- 16 jun 2022
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study
Cheri L Deal, Joel Steelman, Elpis Vlachopapadopoulou, Renata Stawerska, Lawrence A Silverman, Moshe Phillip, Ho-Seong Kim, CheolWoo Ko, Oleg Malievskiy, Jose F Cara et al.
Descritores MeSH
- Dwarfism, Pituitary
- Human Growth Hormone
- Child, Preschool
- Female
- Body Height
- Humans
- Male
- Recombinant Proteins
- Growth Hormone
- Growth Disorders
Veja também
Estudos relacionados
- Effect of Growth Hormone Therapy on Pubertal Timing: Systematic Review and Meta-Analysis
- Efficacy and Safety of Once-Weekly Somatrogon Compared with Once-Daily Somatropin (Genotropin®) in Japanese Children with Pediatric Growth Hormone Deficiency: Results from a Randomized Phase 3 Study
- Trends In Reported Outcomes for Growth Hormone Therapy In Children With Growth Hormone Deficiency
- Sex steroid priming for growth hormone stimulation testing in children and adolescents with short stature: A systematic review